436 related articles for article (PubMed ID: 4037759)
21. Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies.
Barbiroli B; Montagna P; Martinelli P; Lodi R; Iotti S; Cortelli P; Funicello R; Zaniol P
J Cereb Blood Flow Metab; 1993 May; 13(3):469-74. PubMed ID: 8478405
[TBL] [Abstract][Full Text] [Related]
22. Effect of fasting, hypocaloric feeding, and refeeding on the energetics of stimulated rat muscle as assessed by nuclear magnetic resonance spectroscopy.
Mijan de la Torre A; Madapallimattam A; Cross A; Armstrong RL; Jeejeebhoy KN
J Clin Invest; 1993 Jul; 92(1):114-21. PubMed ID: 8325976
[TBL] [Abstract][Full Text] [Related]
23. Muscle energy metabolism in female DMD/BMD carriers: a 31P-MR spectroscopy study.
Barbiroli B; Funicello R; Ferlini A; Montagna P; Zaniol P
Muscle Nerve; 1992 Mar; 15(3):344-8. PubMed ID: 1557082
[TBL] [Abstract][Full Text] [Related]
24. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.
Radda GK; Taylor DJ; Arnold DL
Biochem Soc Trans; 1985 Aug; 13(4):654. PubMed ID: 4029496
[No Abstract] [Full Text] [Related]
25. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study.
Argov Z; Bank WJ; Maris J; Peterson P; Chance B
Neurology; 1987 Feb; 37(2):257-62. PubMed ID: 3808305
[TBL] [Abstract][Full Text] [Related]
26. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy.
Lodi R; Schapira AH; Manners D; Styles P; Wood NW; Taylor DJ; Warner TT
Ann Neurol; 2000 Jul; 48(1):72-6. PubMed ID: 10894218
[TBL] [Abstract][Full Text] [Related]
27. Changes in high-energy phosphates in rat skeletal muscle during acute respiratory acidosis.
Thompson CH; Kemp GJ; Radda GK
Acta Physiol Scand; 1992 Sep; 146(1):15-9. PubMed ID: 1442123
[TBL] [Abstract][Full Text] [Related]
28. [Recording muscle spasm in the musculus erector spinae using in vivo 31P magnetic resonance spectroscopy in patients with chronic lumbalgia and generalized tendomyopathies].
Krapf MW; Müller S; Mennet P; Stratz T; Samborski W; Müller W
Z Rheumatol; 1992; 51(5):229-37. PubMed ID: 1476007
[TBL] [Abstract][Full Text] [Related]
29. Effects of crossclamping the descending aorta on the high-energy phosphates of myocardium and skeletal muscle. A phosphorus 31-nuclear magnetic resonance study.
Balschi JA; Henderson T; Bradley EL; Gelman S
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):346-56. PubMed ID: 8341075
[TBL] [Abstract][Full Text] [Related]
30. [31P-NMR spectroscopy of mitochondrial myopathies: the relation between abnormal energy metabolism and muscle biopsy findings].
Kawai M; Itoh M; Okazawa H; Kamakura K
Rinsho Shinkeigaku; 1989 Feb; 29(2):167-71. PubMed ID: 2546706
[TBL] [Abstract][Full Text] [Related]
31. Energetic metabolism in hypothyroid skeletal muscle, as studied by phosphorus magnetic resonance spectroscopy.
Kaminsky P; Robin-Lherbier B; Brunotte F; Escanye JM; Walker P; Klein M; Robert J; Duc M
J Clin Endocrinol Metab; 1992 Jan; 74(1):124-9. PubMed ID: 1727810
[TBL] [Abstract][Full Text] [Related]
32. Phosphorus metabolites in different muscles of the rat leg by 31P image-selected in vivo spectroscopy.
Madhu B; Lagerwall K; Soussi B
NMR Biomed; 1996 Dec; 9(8):327-32. PubMed ID: 9176886
[TBL] [Abstract][Full Text] [Related]
33. [The effect of hyper- and hypothyroidism on the energy metabolism of skeletal muscles--a study using 31P-magnetic resonance spectroscopy].
Moka D; Theissen P; Linden A; Waters W; Schicha H
Nuklearmedizin; 1991 Jun; 30(3):77-83. PubMed ID: 1871006
[TBL] [Abstract][Full Text] [Related]
34. MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
Jehenson P; Leroy-Willig A; de Kerviler E; Duboc D; Syrota A
AJR Am J Roentgenol; 1993 Aug; 161(2):347-51. PubMed ID: 8333376
[TBL] [Abstract][Full Text] [Related]
35. The current status of magnetic resonance spectroscopy--basic and clinical aspects.
Chan L
West J Med; 1985 Dec; 143(6):773-81. PubMed ID: 3911590
[TBL] [Abstract][Full Text] [Related]
36. [Abnormalities of the skeletal muscle in hypertrophic cardiomyopathy. Spectroscopy using phosphorus-31 nuclear magnetic resonance].
Duboc D; Jehenson P; Tamby JF; Payen JF; Syrota A; Guérin F
Arch Mal Coeur Vaiss; 1991 Feb; 84(2):185-8. PubMed ID: 2021279
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance spectroscopy of normal and diseased muscles.
Chance B; Younkin DP; Kelley R; Bank WJ; Berkowitz HD; Argov Z; Donlon E; Boden B; McCully K; Buist NM
Am J Med Genet; 1986 Dec; 25(4):659-79. PubMed ID: 2947466
[TBL] [Abstract][Full Text] [Related]
38. [31-phosphorus magnetic resonance spectroscopy--a new research instrument in urology. Determination of current status and outlook for clinical use].
Pomer S
Urologe A; 1989 Jul; 28(4):223-30. PubMed ID: 2669305
[TBL] [Abstract][Full Text] [Related]
39. Changes of high-energy phosphorous compounds in skeletal muscle during glucose-induced thermogenesis in man. A 31P MR spectroscopy study.
Thomsen C; Jensen KE; Astrup A; Bülow J; Henriksen O
Acta Physiol Scand; 1989 Nov; 137(3):335-9. PubMed ID: 2596328
[TBL] [Abstract][Full Text] [Related]
40. [Simultaneous measurement of muscle energy metabolism by MRS and frequency-domain NIR spectroscopy].
Zhao J; Ding HS; Ruan MQ; Kime R; Chance B
Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Jun; 25(6):861-5. PubMed ID: 16201358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
